| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepacivirus | 25 | 2023 | 159 | 8.050 |
Why?
|
| Virus Replication | 31 | 2023 | 319 | 5.540 |
Why?
|
| Hepatitis C | 11 | 2023 | 208 | 3.850 |
Why?
|
| Virus Internalization | 14 | 2023 | 39 | 3.360 |
Why?
|
| Viral Nonstructural Proteins | 11 | 2021 | 37 | 3.330 |
Why?
|
| Dengue Virus | 10 | 2022 | 41 | 3.000 |
Why?
|
| Host-Pathogen Interactions | 13 | 2022 | 231 | 2.510 |
Why?
|
| Lipid Metabolism | 10 | 2018 | 196 | 2.330 |
Why?
|
| Virus Release | 4 | 2019 | 6 | 1.990 |
Why?
|
| Autophagy | 7 | 2018 | 149 | 1.920 |
Why?
|
| RNA, Viral | 8 | 2018 | 327 | 1.910 |
Why?
|
| Cell Membrane | 6 | 2019 | 666 | 1.770 |
Why?
|
| Antiviral Agents | 10 | 2022 | 510 | 1.690 |
Why?
|
| Membrane Lipids | 3 | 2016 | 40 | 1.430 |
Why?
|
| Viruses | 4 | 2019 | 78 | 1.380 |
Why?
|
| Hepatocytes | 6 | 2021 | 127 | 1.330 |
Why?
|
| Dengue | 5 | 2022 | 43 | 1.320 |
Why?
|
| Virus Assembly | 4 | 2019 | 21 | 1.250 |
Why?
|
| Claudin-1 | 2 | 2023 | 17 | 1.130 |
Why?
|
| Viral Proteins | 8 | 2022 | 300 | 1.090 |
Why?
|
| Endocytosis | 5 | 2019 | 177 | 1.070 |
Why?
|
| Cell Line | 16 | 2022 | 2468 | 1.030 |
Why?
|
| RNA Viruses | 2 | 2016 | 9 | 1.010 |
Why?
|
| Interferons | 3 | 2023 | 133 | 0.980 |
Why?
|
| Virus Diseases | 3 | 2013 | 97 | 0.940 |
Why?
|
| Cell Culture Techniques | 2 | 2021 | 188 | 0.880 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2014 | 80 | 0.850 |
Why?
|
| Organoids | 2 | 2021 | 61 | 0.810 |
Why?
|
| Interferon-gamma | 1 | 2023 | 444 | 0.780 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 735 | 0.770 |
Why?
|
| Gene Expression Regulation, Viral | 6 | 2022 | 90 | 0.750 |
Why?
|
| RNA Interference | 5 | 2011 | 369 | 0.740 |
Why?
|
| Flavivirus | 2 | 2018 | 6 | 0.740 |
Why?
|
| Fatty Acids | 2 | 2010 | 130 | 0.730 |
Why?
|
| Extracellular Vesicles | 2 | 2022 | 42 | 0.730 |
Why?
|
| Immunity, Innate | 5 | 2022 | 409 | 0.710 |
Why?
|
| Receptors, Virus | 4 | 2021 | 74 | 0.690 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 383 | 0.680 |
Why?
|
| Virion | 2 | 2017 | 59 | 0.660 |
Why?
|
| Optical Imaging | 1 | 2019 | 48 | 0.650 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 268 | 0.630 |
Why?
|
| Lipids | 1 | 2019 | 269 | 0.630 |
Why?
|
| Adenylate Kinase | 1 | 2017 | 13 | 0.610 |
Why?
|
| Proviruses | 1 | 2017 | 15 | 0.610 |
Why?
|
| Humans | 53 | 2024 | 86601 | 0.580 |
Why?
|
| Endoplasmic Reticulum | 4 | 2016 | 250 | 0.580 |
Why?
|
| Flavivirus Infections | 1 | 2016 | 5 | 0.580 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 95 | 0.570 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 182 | 0.550 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 547 | 0.540 |
Why?
|
| Animals | 30 | 2024 | 26581 | 0.530 |
Why?
|
| Phosphatidylinositols | 1 | 2014 | 21 | 0.520 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2014 | 1 | 0.500 |
Why?
|
| Cyclophilin A | 1 | 2014 | 4 | 0.490 |
Why?
|
| Cyclosporins | 1 | 2014 | 59 | 0.490 |
Why?
|
| Receptors, Steroid | 1 | 2014 | 42 | 0.480 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 579 | 0.480 |
Why?
|
| Imidazoles | 1 | 2014 | 162 | 0.480 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2013 | 20 | 0.460 |
Why?
|
| Cholesterol | 2 | 2014 | 356 | 0.440 |
Why?
|
| Herpesvirus 1, Human | 4 | 2000 | 244 | 0.440 |
Why?
|
| RNA | 2 | 2023 | 560 | 0.440 |
Why?
|
| DNA Viruses | 1 | 2012 | 16 | 0.440 |
Why?
|
| Vesicle-Associated Membrane Protein 1 | 1 | 2012 | 1 | 0.430 |
Why?
|
| MicroRNAs | 5 | 2022 | 534 | 0.420 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 43 | 0.410 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2011 | 15 | 0.410 |
Why?
|
| Occludin | 2 | 2023 | 66 | 0.400 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 129 | 0.390 |
Why?
|
| Golgi Apparatus | 1 | 2012 | 117 | 0.390 |
Why?
|
| Mice | 16 | 2024 | 11352 | 0.390 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 266 | 0.390 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 246 | 0.390 |
Why?
|
| Fatty Acid Synthases | 1 | 2010 | 8 | 0.390 |
Why?
|
| Virus Latency | 3 | 2000 | 33 | 0.380 |
Why?
|
| Genes, Viral | 1 | 2009 | 116 | 0.360 |
Why?
|
| Protein Interaction Mapping | 3 | 2022 | 82 | 0.350 |
Why?
|
| Protein Transport | 4 | 2019 | 411 | 0.320 |
Why?
|
| ErbB Receptors | 2 | 2023 | 485 | 0.320 |
Why?
|
| Minor Histocompatibility Antigens | 3 | 2014 | 39 | 0.320 |
Why?
|
| HEK293 Cells | 4 | 2022 | 615 | 0.320 |
Why?
|
| Pyrrolidines | 2 | 2021 | 58 | 0.310 |
Why?
|
| Endoribonucleases | 3 | 2022 | 92 | 0.290 |
Why?
|
| Kidney | 2 | 2022 | 1241 | 0.280 |
Why?
|
| Gene Silencing | 2 | 2006 | 172 | 0.280 |
Why?
|
| Endopeptidases | 1 | 2006 | 116 | 0.280 |
Why?
|
| Interferon-alpha | 1 | 2006 | 233 | 0.270 |
Why?
|
| Protein Binding | 5 | 2022 | 1456 | 0.270 |
Why?
|
| Genome, Viral | 3 | 2018 | 74 | 0.260 |
Why?
|
| gamma-Globulins | 1 | 2024 | 16 | 0.250 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 112 | 0.240 |
Why?
|
| Clathrin | 1 | 2023 | 29 | 0.240 |
Why?
|
| Gene Expression Regulation | 2 | 2022 | 1920 | 0.240 |
Why?
|
| Antibodies, Viral | 3 | 2021 | 293 | 0.240 |
Why?
|
| Melphalan | 1 | 2024 | 97 | 0.240 |
Why?
|
| Open Reading Frames | 3 | 2000 | 117 | 0.230 |
Why?
|
| Replicon | 1 | 2002 | 8 | 0.230 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 9 | 0.220 |
Why?
|
| GTP Phosphohydrolases | 1 | 2023 | 71 | 0.220 |
Why?
|
| Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
| Pluripotent Stem Cells | 1 | 2022 | 31 | 0.210 |
Why?
|
| A549 Cells | 4 | 2022 | 39 | 0.210 |
Why?
|
| Coronavirus OC43, Human | 1 | 2021 | 7 | 0.210 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2022 | 55 | 0.210 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 53 | 0.200 |
Why?
|
| Signal Transduction | 4 | 2017 | 3241 | 0.200 |
Why?
|
| Adaptor Protein Complex 1 | 2 | 2018 | 2 | 0.200 |
Why?
|
| Papain | 1 | 2021 | 6 | 0.200 |
Why?
|
| Thymine | 1 | 2021 | 17 | 0.200 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 67 | 0.200 |
Why?
|
| Immunoconjugates | 1 | 2021 | 106 | 0.190 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 2426 | 0.190 |
Why?
|
| Peptide Hydrolases | 1 | 2021 | 100 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2020 | 11 | 0.190 |
Why?
|
| Thiazoles | 1 | 2021 | 131 | 0.190 |
Why?
|
| Disease Resistance | 1 | 2020 | 18 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 388 | 0.190 |
Why?
|
| Nanoparticles | 1 | 2021 | 157 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 135 | 0.180 |
Why?
|
| Tetraspanin 28 | 2 | 2018 | 3 | 0.180 |
Why?
|
| Cells | 1 | 2019 | 32 | 0.180 |
Why?
|
| Base Sequence | 5 | 2007 | 2330 | 0.170 |
Why?
|
| Herpes Simplex | 1 | 2000 | 202 | 0.170 |
Why?
|
| Exoribonucleases | 1 | 2018 | 9 | 0.170 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2018 | 4 | 0.170 |
Why?
|
| Lipid Droplet Associated Proteins | 1 | 2018 | 1 | 0.170 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2018 | 13 | 0.170 |
Why?
|
| Lipid Droplets | 1 | 2018 | 16 | 0.160 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2018 | 4 | 0.160 |
Why?
|
| Adaptor Protein Complex 4 | 1 | 2018 | 2 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2019 | 165 | 0.160 |
Why?
|
| Liver | 2 | 2013 | 1229 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 639 | 0.160 |
Why?
|
| Membrane Proteins | 3 | 2018 | 1196 | 0.150 |
Why?
|
| Vero Cells | 4 | 2022 | 100 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 29 | 0.150 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 48 | 0.150 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2017 | 90 | 0.150 |
Why?
|
| Immediate-Early Proteins | 2 | 1997 | 164 | 0.150 |
Why?
|
| Tight Junctions | 1 | 2018 | 149 | 0.150 |
Why?
|
| DNA Replication | 1 | 2017 | 164 | 0.140 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 819 | 0.140 |
Why?
|
| Bromovirus | 1 | 2016 | 1 | 0.140 |
Why?
|
| Hordeum | 1 | 2016 | 10 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 48 | 0.140 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 134 | 0.140 |
Why?
|
| Flunarizine | 1 | 2015 | 1 | 0.140 |
Why?
|
| Viral Fusion Proteins | 1 | 2015 | 10 | 0.140 |
Why?
|
| Pyrroles | 1 | 2017 | 184 | 0.140 |
Why?
|
| Plant Diseases | 1 | 2016 | 75 | 0.130 |
Why?
|
| Glycolysis | 1 | 2016 | 129 | 0.130 |
Why?
|
| Cell Survival | 1 | 2018 | 969 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 279 | 0.130 |
Why?
|
| Indoles | 1 | 2017 | 318 | 0.130 |
Why?
|
| Carbamates | 1 | 2014 | 19 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 451 | 0.130 |
Why?
|
| Valine | 1 | 2014 | 69 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2018 | 673 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 1997 | 1135 | 0.120 |
Why?
|
| Models, Molecular | 3 | 2021 | 1286 | 0.120 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2013 | 7 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 1540 | 0.110 |
Why?
|
| Viral Tropism | 1 | 2012 | 4 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 927 | 0.110 |
Why?
|
| RNA Virus Infections | 1 | 2012 | 3 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1204 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 589 | 0.110 |
Why?
|
| DNA Virus Infections | 1 | 2012 | 6 | 0.110 |
Why?
|
| Hepatitis Viruses | 1 | 2012 | 1 | 0.110 |
Why?
|
| Biological Assay | 1 | 2012 | 78 | 0.110 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 102 | 0.100 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2012 | 25 | 0.100 |
Why?
|
| Virus Physiological Phenomena | 1 | 2011 | 8 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 64 | 0.100 |
Why?
|
| Genotype | 4 | 2015 | 1850 | 0.100 |
Why?
|
| Calreticulin | 1 | 2011 | 13 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2022 | 83 | 0.100 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 40 | 0.100 |
Why?
|
| Lung | 3 | 2022 | 1170 | 0.100 |
Why?
|
| Phagosomes | 1 | 2011 | 39 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 1208 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2013 | 238 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2022 | 1981 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2021 | 156 | 0.100 |
Why?
|
| Cryoelectron Microscopy | 1 | 2011 | 91 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2011 | 281 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 373 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 164 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 1384 | 0.090 |
Why?
|
| Virus Attachment | 1 | 2009 | 6 | 0.090 |
Why?
|
| Cricetinae | 1 | 2010 | 560 | 0.090 |
Why?
|
| Gene Library | 1 | 2009 | 130 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 104 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 316 | 0.090 |
Why?
|
| Endosomes | 1 | 2009 | 75 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 3030 | 0.080 |
Why?
|
| Macrophages | 2 | 2022 | 554 | 0.080 |
Why?
|
| Rabbits | 3 | 1997 | 636 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2021 | 881 | 0.080 |
Why?
|
| Janus Kinase 1 | 1 | 2006 | 15 | 0.070 |
Why?
|
| Ubiquitins | 1 | 2006 | 38 | 0.070 |
Why?
|
| STAT1 Transcription Factor | 1 | 2006 | 52 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 63 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2007 | 203 | 0.070 |
Why?
|
| HLA Antigens | 1 | 2007 | 232 | 0.070 |
Why?
|
| DNA | 2 | 2004 | 1294 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 2357 | 0.070 |
Why?
|
| Herpesviridae | 1 | 2005 | 14 | 0.070 |
Why?
|
| DNA Probes | 1 | 2004 | 77 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2004 | 45 | 0.060 |
Why?
|
| Binding Sites | 3 | 2020 | 1098 | 0.060 |
Why?
|
| Viral Structural Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2024 | 32 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2005 | 351 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2004 | 178 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 2004 | 94 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 1 | 2005 | 217 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 1041 | 0.060 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2022 | 17 | 0.060 |
Why?
|
| Inositol | 1 | 2022 | 15 | 0.060 |
Why?
|
| Cytokines | 1 | 2006 | 776 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 689 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2022 | 92 | 0.050 |
Why?
|
| Virus Inactivation | 1 | 2021 | 4 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2022 | 77 | 0.050 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 23 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 15 | 0.050 |
Why?
|
| Semiconductors | 1 | 2021 | 11 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 3092 | 0.050 |
Why?
|
| Thiadiazoles | 1 | 2021 | 12 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 458 | 0.050 |
Why?
|
| DNA Primers | 1 | 2002 | 543 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 1074 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 64 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2022 | 669 | 0.050 |
Why?
|
| Polyproteins | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2818 | 0.050 |
Why?
|
| Uridine | 1 | 2021 | 56 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2021 | 206 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 143 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 177 | 0.050 |
Why?
|
| Viral Load | 1 | 2021 | 148 | 0.050 |
Why?
|
| Norovirus | 1 | 2020 | 13 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2020 | 28 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2022 | 498 | 0.050 |
Why?
|
| Light | 1 | 2021 | 289 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2021 | 167 | 0.050 |
Why?
|
| Benzamides | 1 | 2021 | 229 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2020 | 27 | 0.050 |
Why?
|
| Polymers | 1 | 2021 | 202 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2020 | 307 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2021 | 347 | 0.050 |
Why?
|
| Piperidines | 1 | 2021 | 181 | 0.050 |
Why?
|
| Ligands | 1 | 2021 | 433 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1106 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 485 | 0.040 |
Why?
|
| Asthma | 1 | 2007 | 955 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 309 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 363 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 77 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1538 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 559 | 0.040 |
Why?
|
| Methionine | 1 | 1997 | 66 | 0.040 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Ebolavirus | 1 | 2017 | 6 | 0.040 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2017 | 11 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 55 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 279 | 0.040 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 126 | 0.040 |
Why?
|
| Point Mutation | 1 | 1997 | 246 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2017 | 303 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 1997 | 201 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 2016 | 117 | 0.030 |
Why?
|
| Transfection | 1 | 1997 | 896 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 740 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1014 | 0.030 |
Why?
|
| Models, Biological | 2 | 2013 | 1749 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 379 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 1565 | 0.030 |
Why?
|
| Skin | 1 | 1997 | 554 | 0.030 |
Why?
|
| Phenotype | 2 | 1997 | 2377 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 2216 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2016 | 434 | 0.030 |
Why?
|
| Drug Resistance, Viral | 1 | 2012 | 51 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2011 | 30 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2011 | 48 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2011 | 35 | 0.030 |
Why?
|
| Luciferases | 1 | 2011 | 118 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 62 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2011 | 145 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 268 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 236 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2011 | 265 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 127 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 303 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 223 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 646 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 302 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 3967 | 0.020 |
Why?
|
| Female | 3 | 2022 | 44507 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 503 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 92 | 0.020 |
Why?
|
| HLA-G Antigens | 1 | 2007 | 52 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 696 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 473 | 0.020 |
Why?
|
| Motion | 1 | 2004 | 85 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 18402 | 0.020 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 2004 | 2 | 0.020 |
Why?
|
| Alleles | 1 | 2007 | 1127 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 332 | 0.010 |
Why?
|
| HIV-1 | 1 | 2004 | 163 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2004 | 464 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 428 | 0.010 |
Why?
|
| Male | 2 | 2017 | 40956 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 2356 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 2270 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 5416 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1996 | 52 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 199 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 439 | 0.010 |
Why?
|